4//SEC Filing
BHONSLE SUNIL 4
Accession 0001144204-19-018017
CIK 0000910267other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:30 PM ET
Size
5.6 KB
Accession
0001144204-19-018017
Insider Transaction Report
Form 4
BHONSLE SUNIL
DirectorPresident
Transactions
- Award
Option to Purchase Common Stock
2019-04-02+200,000→ 200,000 totalExercise: $1.75Exp: 2029-04-02→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The options vest as to 83,334 shares on the grant date with the balance to vest at such time, if ever, as the Company receives shareholder approval of the Board's amendment to Section 5.1 of the Company's option plan to increase the limitation on the number of awards granted to a single individual in any calendar year from 83,334 to 250,000.
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeother
Related Parties
1- filerCIK 0001180755
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:30 PM ET
- Size
- 5.6 KB